03.12.2012 Views

ANNUAL REPORT 2007 | 2008 - Gimv

ANNUAL REPORT 2007 | 2008 - Gimv

ANNUAL REPORT 2007 | 2008 - Gimv

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

19. GOODWILL IMPAIRMENT<br />

The goodwill recorded in the books relates solely to the buy-out<br />

companies. This goodwill is tested annually for impairment by<br />

comparing the carrying value of the subsidiaries in question with<br />

their fair value. In <strong>2007</strong>-<strong>2008</strong> this produced a total impairment<br />

loss of EUR 7 308.<br />

20. FINANCIAL ASSETS AT FAIR VALUE THROUGH<br />

PROFIT AND LOSS (IN EUR 000)<br />

The fi nancial assets, consisting of shareholdings by <strong>Gimv</strong> and<br />

its subsidiaries, reduced by EUR 42 313.<br />

In the <strong>2007</strong>-<strong>2008</strong> fi nancial year, the <strong>Gimv</strong> group invested<br />

EUR 123 319 in shareholdings. The main investments were VAG<br />

Armaturen and Rollinvest NV (Corporate Investment Belgium),<br />

the Halder-<strong>Gimv</strong> Germany Fund (Corporate Investment<br />

Germany), Metris and Telenet Group Holding (ICT) and Ablynx<br />

and Ambit Biosciences (Life Sciences).<br />

Divestments totalling EUR 212 199 were also undertaken. The<br />

main divestments were: Lyceum Capital, Alfacam, Jensen and<br />

Dujardin Foods (Corporate Investment Belgium), the Halder-<br />

<strong>Gimv</strong> Germany Fund (Corporate Investment Germany), Holowell<br />

(Corporate Investment Netherlands), Telenet Group Holding and<br />

Business Architects (ICT) and deVGen (Life Sciences).<br />

Unrealized capital gains amounted to EUR 34 644. These gains<br />

refl ect the periodical valuation exercises covering the entire portfolio.<br />

<strong>Gimv</strong> group values listed shareholdings at their bid price<br />

and unlisted shareholdings based on the valuation methods<br />

most appropriate for the particular type of investment, in line<br />

with the European Private Equity and Venture Capital Valuation<br />

Guidelines.<br />

<strong>2007</strong>-<strong>2008</strong> 2006-<strong>2007</strong><br />

1. Opening balance 690 811 557 477<br />

1.1. Investments 123 319 131 421<br />

1.2. Acquisition through business combination -<br />

1.3. Divestments (-) -212 199 -134 048<br />

1.4. Disposal of subsidiaries -<br />

1.5. Unrealized change (increase (+), decrease (-) in fair value) 34 644 135 441<br />

1.6. Increase (decrease) translation differences -<br />

1.7. Other (increase (+), decrease (-)) 11 823 520<br />

2. Closing balance<br />

Of which<br />

648 398 690 811<br />

Shares - listed 122 651 247 598<br />

Shares - unlisted 525 747 443 213<br />

Change in fair value recognised in profi t & loss during the period 34 644 135 441<br />

Estimated using a valuation technique 81 222 72 299<br />

Determined directly -50 794 63 142<br />

21. LOANS TO INVESTEE COMPANIES<br />

(IN EUR 000)<br />

Loans totalling EUR 49 811 were made, the largest being to<br />

Metris, Mondi Foods NV, Rollinvest NV, Verhaeren NV, VAG<br />

Armaturen, Fortress Warehousing & Distribution and Impression<br />

International. Loans totalling EUR 15 606 were repaid, with<br />

the largest repayments coming from Alfacam NV, Fortress<br />

Warehousing & Distribution, Mondi Foods NV, BAI Beheer<br />

and Elixent. The impact of valuation movements and transfers<br />

amounted to – EUR 19 944.<br />

| 135

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!